Concentrix Corporation (CNXC) Key Metrics
CNXC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.70B
- Enterprise value
- $6.17B
- P/E (TTM)
- — 10-yr median 16.2
- Forward P/E
- 2.7
- PEG ratio
- 0.38
- Price / sales
- 0.2 10-yr median 0.8
- Price / book
- 0.7 10-yr median 1.5
- EV / EBITDA
- 11.1 10-yr median 9.6
- Dividend yield
- 5.31% $1.48 a year
- Beta
- 0.51
CNXC key metrics, FY2017–FY2025
Fiscal year ended November 30, 2025 · U.S. dollarsCNXC valuation Price multiples at each fiscal year-end price.
CNXC returns How much profit the business earns on the capital it uses.
CNXC per-share figures Results divided by the shares outstanding at year-end.
CNXC financial health Debt, liquidity and how easily interest is covered.
CNXC efficiency & capital use Working capital cycle and where the cash goes.
CNXC valuation history
CNXC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CNXC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CNXC cash returned to shareholders
CNXC price vs earnings per share
CNXC key metrics
FY2017–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||
| Market capitalization | $2.28B | $2.93B | $5.08B | $6.33B | $8.62B | $4.13B | — | — | — |
| Enterprise value | $6.59B | $8.09B | $10.35B | $8.90B | $9.74B | $5.68B | — | — | — |
| P/E ratio | — | 11.6 | 16.2 | 14.6 | 21.2 | 25.0 | — | — | — |
| Price / sales | 0.2 | 0.3 | 0.7 | 1.0 | 1.5 | 0.9 | — | — | — |
| Price / book | 0.8 | 0.7 | 1.2 | 2.3 | 3.3 | 1.8 | — | — | — |
| Price / free cash flow | 4.0 | 6.8 | 10.2 | 13.7 | 23.6 | 12.3 | — | — | — |
| Price / operating cash flow | 2.8 | 4.4 | 7.5 | 10.5 | 16.8 | 8.1 | — | — | — |
| EV / sales | 0.7 | 0.8 | 1.5 | 1.4 | 1.7 | 1.2 | — | — | — |
| EV / EBITDA | — | 6.1 | 15.7 | 9.0 | 11.4 | 9.6 | — | — | — |
| EV / free cash flow | 11.5 | 18.9 | 20.8 | 19.3 | 26.7 | 16.9 | — | — | — |
| Earnings yield | −56.1% | 8.6% | 6.2% | 6.9% | 4.7% | 4.0% | — | — | — |
| Free cash flow yield | 25.1% | 14.7% | 9.8% | 7.3% | 4.2% | 8.1% | — | — | — |
| Dividend yield | 3.9% | 2.9% | 1.3% | 0.8% | 0.2% | 0.3% | — | — | — |
| Shareholder yield (dividends + buybacks) | 12.2% | 8.0% | 2.9% | 2.9% | 0.8% | 0.3% | — | — | — |
| Share price at fiscal year-end | $36.21 | $44.95 | $93.99 | $122.38 | $166.00 | $80.00 | — | — | — |
| Per share | |||||||||
| Revenue per share | $155.93 | $147.81 | $131.73 | $122.24 | $107.62 | $91.46 | $91.24 | $47.64 | $38.49 |
| Earnings per share | −$20.30 | $3.86 | $5.81 | $8.41 | $7.81 | $3.19 | $2.27 | $0.93 | $1.40 |
| Operating cash flow per share | $12.81 | $10.26 | $12.55 | $11.61 | $9.90 | $9.84 | $8.72 | $4.11 | $3.26 |
| Free cash flow per share | $9.09 | $6.59 | $9.21 | $8.90 | $7.03 | $6.52 | $6.56 | $2.32 | $1.73 |
| Cash per share | $5.19 | $6.60 | $9.56 | $3.04 | $3.53 | $3.03 | $1.62 | $2.39 | — |
| Book value per share | $43.55 | $62.08 | $76.71 | $52.10 | $50.47 | $44.61 | $28.48 | $25.53 | — |
| Tangible book value per share | −$45.83 | −$49.70 | −$69.25 | −$23.08 | $2.91 | −$6.45 | −$25.07 | −$30.18 | — |
| Dividends per share | $1.42 | $1.29 | $1.18 | $1.03 | $0.25 | $0.25 | $0.25 | $0.25 | — |
| Capex per share | $3.72 | $3.67 | $3.34 | $2.71 | $2.87 | $3.32 | $2.15 | $1.79 | $1.52 |
| Debt per share | $73.61 | $86.02 | $107.28 | $52.64 | $25.23 | $33.03 | $40.06 | $43.38 | — |
| Shares outstanding | 63.0M | 65.1M | 54.0M | 51.7M | 51.9M | 51.6M | 51.6M | 51.7M | 51.7M |
| Change in shares outstanding | −3.2% | +20.5% | +4.4% | −0.3% | +0.6% | 0.0% | −0.2% | 0.0% | — |
| Returns & profitability | |||||||||
| Return on equity (ROE) | −37.7% | 6.1% | 9.2% | 16.4% | 16.5% | 8.7% | 8.4% | 3.7% | — |
| Return on invested capital (ROIC) | 5.9% | 5.4% | 6.9% | 10.2% | 11.0% | 5.2% | 4.9% | 2.1% | — |
| Return on assets (ROA) | −11.2% | 2.1% | 3.3% | 7.4% | 7.9% | 3.4% | 2.5% | 1.0% | — |
| Return on tangible assets | −24.9% | 5.3% | 6.8% | 15.7% | 15.7% | 6.5% | 6.2% | 2.6% | — |
| Free cash flow margin | 5.8% | 4.5% | 7.0% | 7.3% | 6.5% | 7.1% | 7.2% | 4.9% | 4.5% |
| Income quality (OCF / net income) | — | 2.66 | 2.16 | 1.38 | 1.27 | 3.08 | 3.84 | 4.40 | 2.33 |
| Financial health | |||||||||
| Total debt | $4.64B | $5.60B | $5.79B | $2.72B | $1.31B | $1.70B | $2.07B | $2.24B | — |
| Cash & short-term investments | $327.3M | $429.6M | $516.5M | $157.5M | $183.0M | $156.4M | $83.5M | $123.4M | — |
| Net debt | $4.31B | $5.17B | $5.28B | $2.57B | $1.13B | $1.55B | $1.98B | $2.12B | — |
| Debt / equity | 1.69 | 1.39 | 1.40 | 1.01 | 0.50 | 0.74 | 1.41 | 1.70 | — |
| Debt / assets | 0.43 | 0.47 | 0.46 | 0.41 | 0.26 | 0.33 | 0.44 | 0.47 | — |
| Net debt / EBITDA | — | 3.89 | 7.98 | 2.61 | 1.32 | 2.61 | 3.29 | 6.98 | — |
| Current ratio | 1.40 | 1.42 | 1.38 | 1.55 | 1.59 | 1.41 | 0.48 | 0.43 | — |
| Quick ratio | 1.40 | 1.42 | 1.27 | 1.55 | 1.59 | 1.41 | 0.48 | 0.43 | — |
| Interest coverage | 2.1 | 1.9 | 3.3 | 9.1 | 24.8 | 6.4 | 3.2 | 3.8 | 4.8 |
| Working capital | $888.2M | $846.6M | $784.6M | $622.2M | $574.9M | $414.7M | −$1.40B | −$1.71B | — |
| Invested capital | $7.06B | $9.21B | $9.42B | $5.26B | $3.75B | $3.85B | $3.45B | $3.44B | — |
| Tangible asset value | −$2.89B | −$3.23B | −$3.74B | −$1.19B | $151.2M | −$332.9M | −$1.29B | −$1.56B | — |
| Net current asset value | −$4.93B | −$5.11B | −$5.49B | −$2.22B | −$883.0M | −$1.45B | −$1.88B | −$2.15B | — |
| Graham number | — | $73.43 | $100.15 | $99.29 | $94.19 | $56.62 | $38.15 | $23.16 | — |
| Graham net-net per share | −$98.24 | −$93.39 | −$116.73 | −$53.61 | −$25.76 | −$36.98 | −$45.28 | −$50.56 | — |
| Capital allocation | |||||||||
| Dividends paid | $89.6M | $83.8M | $63.5M | $53.4M | $13.1M | $13.1M | $13.1M | $13.1M | — |
| Share buybacks (net) | $188.7M | $149.5M | $81.2M | $133.3M | $57.5M | $0 | — | — | — |
| Dividend payout ratio | — | 33.4% | 20.2% | 12.3% | 3.2% | 7.9% | 11.2% | 27.1% | — |
| Dividends + buybacks / free cash flow | 48.6% | 54.4% | 29.1% | 40.5% | 19.3% | 3.9% | 3.9% | 10.9% | — |
| Capex / revenue | 2.4% | 2.5% | 2.5% | 2.2% | 2.7% | 3.6% | 2.4% | 3.8% | 4.0% |
| Capex / operating cash flow | 29.1% | 35.8% | 26.6% | 23.3% | 29.0% | 33.8% | 24.7% | 43.6% | 46.7% |
| Capex / depreciation | 0.36 | 0.34 | 0.46 | 0.45 | 0.54 | 0.62 | 0.36 | 0.60 | 0.61 |
| Stock-based compensation / revenue | 1.0% | 1.0% | 0.9% | 0.7% | 0.6% | 0.3% | 0.2% | 0.3% | 0.3% |
| SG&A / revenue | 28.8% | 29.7% | 26.9% | 25.6% | 25.0% | 28.7% | 30.9% | 32.2% | 31.9% |
| Efficiency | |||||||||
| Days sales outstanding | 72.9 | 72.4 | 84.1 | 75.0 | 74.8 | 81.1 | 76.0 | 139.8 | — |
| Days of inventory on hand | — | — | 17.8 | — | — | — | 0.5 | 1.1 | — |
| Days payables outstanding | 13.0 | 13.4 | 16.3 | 13.0 | 13.6 | 19.9 | 20.3 | 32.7 | — |
| Cash conversion cycle (days) | 59.9 | 59.0 | 85.6 | 61.9 | 61.2 | 61.3 | 56.2 | 108.2 | — |
| Receivables turnover | 5.01 | 5.04 | 4.34 | 4.87 | 4.88 | 4.50 | 4.80 | 2.61 | — |
| Payables turnover | 28.12 | 27.22 | 22.42 | 28.00 | 26.80 | 18.39 | 18.01 | 11.16 | — |
| Inventory turnover | — | — | 20.51 | — | — | — | 708.60 | 339.40 | — |
| Asset turnover | 0.86 | 0.79 | 0.74 | 1.08 | 1.09 | 0.96 | 1.00 | 0.52 | — |
| Average receivables | $1.96B | $1.91B | $1.64B | $1.30B | $1.14B | $1.05B | $979.9M | $943.6M | — |
| Average payables | $227.3M | $226.7M | $202.4M | $145.3M | $135.0M | $166.3M | $164.3M | $136.6M | — |
| Average inventory | — | — | $221.2M | — | — | — | $4.2M | $4.5M | — |
| Intangibles / total assets | 52.3% | 60.7% | 63.1% | 58.3% | 48.9% | 50.9% | 59.4% | 60.4% | — |
Computed from CNXC's annual financial statements (latest annual report filed January 28, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CNXC valuation and financial ratios
Concentrix earned a return on equity of −37.7% and a return on invested capital of 5.9% in fiscal 2025. It ended the year with $4.6 billion of debt and $327.3 million in cash and short-term investments, net debt of $4.3 billion. It returned $278.3 million to shareholders: $89.6 million in dividends and $188.7 million in share buybacks, 49% of free cash flow. The share count rose 21.9% from 51.7M to 63.0M over 8 years.
See the CNXC income statement, the CNXC chart for price history, or the CNXC stock overview for the latest quote and news.
CNXC key metrics FAQ
What is Concentrix's return on equity?
Concentrix's return on equity (ROE) was −37.7% in fiscal 2025: net income of -$1.3 billion on average shareholders' equity of $3.4 billion.
What is Concentrix's ROIC?
Concentrix's return on invested capital was 5.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Concentrix have?
Concentrix had total debt of $4.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.69.
What is Concentrix's dividend yield?
Concentrix's forward dividend yield is 5.31%. Concentrix paid $89.6 million in dividends in fiscal 2025 ($1.42 per share), a payout ratio of —.
Does Concentrix buy back its shares?
Yes. Concentrix spent $188.7 million on net share repurchases in fiscal 2025 Shares outstanding changed −3.2% over the year, to 63.0M..
What is Concentrix's free cash flow yield?
Concentrix generated $572.5 million of free cash flow in fiscal 2025, a free cash flow yield of 25.1% on its market value at year-end ($2.3 billion).
What is Concentrix's current ratio?
Concentrix's current ratio was 1.40 at the end of fiscal 2025: current assets were 1.40 times current liabilities.